{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T15:18:22Z","timestamp":1787930302231,"version":"build-2784847793"},"update-to":[{"DOI":"10.1002\/14651858.cd005943.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T00:00:00Z","timestamp":1533513600000}}],"reference-count":118,"publisher":"Wiley","issue":"9","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd005943.pub5","type":"journal-article","created":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T07:23:40Z","timestamp":1533626620000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Progestogen for treating threatened miscarriage"],"prefix":"10.1002","volume":"2018","author":[{"given":"Hayfaa A","family":"Wahabi","sequence":"first","affiliation":[{"name":"King Saud University; Chair of Evidence-Based Healthcare and Knowledge Translation; Riyadh Saudi Arabia 11451"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amel A","family":"Fayed","sequence":"additional","affiliation":[{"name":"Princess Nourah Bint Abdulrahman University; College of Medicine, Clinical Department; Khurais Road King Abdulaziz Medical City Riyadh Saudi Arabia 22490"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samia A","family":"Esmaeil","sequence":"additional","affiliation":[{"name":"King Saud University; Department of Family and Community Medicine; Riyadh Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khawater Hassan","family":"Bahkali","sequence":"additional","affiliation":[{"name":"King Saud University; Department of Family and Community Medicine; Riyadh Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,8,6]]},"reference":[{"issue":"1-2","key":"10.1002\/14651858.CD005943.pub5-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jri.2013.01.004","article-title":"Progesterone and threatened abortion: a randomized clinical trial on endocervical cytokine concentrations","volume":"98","author":"Alimohamadi","year":"2013","journal-title":"Journal of Reproductive Immunology"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.maturitas.2009.11.013","article-title":"Dydrogesterone support in threatened miscarriage","volume":"65 Suppl 1","author":"El-Zibdeh","year":"2009","journal-title":"Maturitas"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0003|cit3","first-page":"26","article-title":"Double-blind controlled trial of progesterone substitution in threatened abortion","volume":"8","author":"Gerhard","year":"1987","journal-title":"Biological Research in Pregnancy and Perinatology"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1196\/annals.1335.022","article-title":"Effects of vaginal progesterone on pain and uterine contractility in patients with threatened abortion before twelve weeks of pregnancy","volume":"1034","author":"Palagiano","year":"2004","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.maturitas.2009.11.016","article-title":"Dydrogesterone in threatened miscarriage: a Malaysian experience","volume":"65 Suppl 1","author":"Pandian","year":"2009","journal-title":"Maturitas"},{"issue":"1","key":"10.1002\/14651858.CD005943.pub5-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/jcu.22384","article-title":"Effect of micronized progesterone on fetal-placental volume in first-trimester threatened abortion","volume":"45","author":"Turgal","year":"2017","journal-title":"Journal of Clinical Ultrasound"},{"issue":"3","key":"10.1002\/14651858.CD005943.pub5-BIB0007|cit7","first-page":"147","article-title":"The effect of progesterone suppositories on threatened abortion: a randomized clinical trial","volume":"15","author":"Yassaee","year":"2014","journal-title":"Journal of Reproduction & Infertility"},{"issue":"1","key":"10.1002\/14651858.CD005943.pub5-BIB0008|cit8","first-page":"261","article-title":"Role of progesterone in the management of threatened miscarriage","volume":"6","author":"Akhtar","year":"2012","journal-title":"Pakistan Journal of Medical and Health Sciences"},{"issue":"2","key":"10.1002\/14651858.CD005943.pub5-BIB0009|cit9","first-page":"162","article-title":"Comparison of risk of preterm labor between vaginal progesterone and 17-alpha-hydroxy-progesterone caproate in women with threatened abortion: a randomized clinical trial","volume":"10","author":"Beigi","year":"2016","journal-title":"International Journal of Fertility & Sterility"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0010|cit10","first-page":"139","article-title":"The treatment of threatened abortion","volume":"37","author":"Berle","year":"1977","journal-title":"Geburtshilfe und Frauenheilkunde"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0011|cit11","first-page":"353","article-title":"Is hormonal therapy still justified in imminent abortion","volume":"184","author":"Berle","year":"1980","journal-title":"Zeitschrift fur Geburtshilfe und Perinatologie"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0002-9378(16)35945-2","article-title":"Effect of medroxyprogesterone acetate upon the duration and characteristics of human gestation and labor","volume":"83","author":"Brenner","year":"1962","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000292421","article-title":"A randomized study comparing the efficacy of reducing the spontaneous abortion rate following lymphocyte immunotherapy and progesterone treatment vs progesterone alone in primary habitual aborters","volume":"39","author":"Check","year":"1995","journal-title":"Gynecologic and Obstetric Investigation"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0014|cit14","unstructured":"Chye TT ChiCTR-IOR-17011593 The randomised controlled trial of micronised progesterone and dydrogesterone (TRoMaD) for threatened miscarriage chictr.org.cn\/showproj.aspx?proj=19668"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0015|cit15","unstructured":"Chye TT ChiCTR-IPR-14005251 Micronised progesterone versus dydrogesterone: a randomised controlled trial chictr.org.cn\/showproj.aspx?proj=9539http:\/\/www.chictr.org.cn\/showproj.aspx?proj=9539"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0301-2115(01)00418-3","article-title":"A randomised trial of progesterone prophylaxis after midtrimester amniocentesis","volume":"100","author":"Corrado","year":"2002","journal-title":"European Journal of Obstetrics & Gynecology and Reproductive Biology"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0017|cit17","unstructured":"Costantino D NCT02601898 Vaginal administration of alpha lipoic acid vs progesterone for the subchorionic hematoma treatment clinicaltrials.gov\/show\/NCT02601898"},{"issue":"8","key":"10.1002\/14651858.CD005943.pub5-BIB0018|cit18","first-page":"1656","article-title":"Resolution of subchorionic hematoma and symptoms of threatened miscarriage using vaginal alpha lipoic acid or progesterone: clinical evidences","volume":"20","author":"Costantino","year":"2016","journal-title":"European Review for Medical and Pharmacological Sciences"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0002-9378(16)39122-0","article-title":"The management of threatened abortion: a study of 100 cases","volume":"60","author":"Crowder","year":"1950","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD005943.pub5-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.fertnstert.2006.07.1506","article-title":"Uteroplacental circulation in early pregnancy complicated by threatened abortion supplemented with vaginal micronized progesterone or oral dydrogesterone","volume":"87","author":"Czajkowski","year":"2007","journal-title":"Fertility and Sterility"},{"issue":"3 Suppl 1","key":"10.1002\/14651858.CD005943.pub5-BIB0021|cit21","first-page":"S77","article-title":"Randomized study comparing the efficacy of reducing spontaneous abortion following treatment with progesterone and human chorionic gonadotropin (hCG)","volume":"70","author":"Zibdeh","year":"2000","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0022|cit22","unstructured":"El Zibdeh M Randomized clinical trial comparing the efficacy of dydrogesterone and human chorionic gonadotropin [abstract] 10th World Congress on Menopause; 2002 July 10-14; Berlin, Germany 2002 136"},{"issue":"5","key":"10.1002\/14651858.CD005943.pub5-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.jsbmb.2005.08.007","article-title":"Dydrogesterone in the reduction of recurrent spontaneous abortion","volume":"97","author":"El-Zibdeh","year":"2005","journal-title":"Journal of Steroid Biochemistry & Molecular Biology"},{"issue":"4","key":"10.1002\/14651858.CD005943.pub5-BIB0024|cit24","first-page":"155","article-title":"The effect of dydrogesterone on placental angiogenesis and pregnancy outcomes in women with threatened miscarriages","volume":"37","author":"Famina","year":"2015","journal-title":"Giornale Italiano di Ostetricia e Ginecologia"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0025|cit25","first-page":"1461","article-title":"An attempted double-blind controlled trial of progesterone therapy in habitual abortion","volume":"128","author":"Fuchs","year":"1966","journal-title":"Ugeskrift for Laeger"},{"issue":"7","key":"10.1002\/14651858.CD005943.pub5-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1001\/jama.1964.03060330031008","article-title":"Double-blind trial of a progestin in habitual abortion","volume":"188","author":"Goldzieher","year":"1964","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1111\/j.1471-0528.1965.tb01536.x","article-title":"A double-blind study of progestogen treatment in spontaneous abortion (preliminary report)","volume":"72","author":"Govaerts-Videtzky","year":"1965","journal-title":"Journal of Obstetrics and Gynaecology of the British Commonwealth"},{"issue":"Suppl S1","key":"10.1002\/14651858.CD005943.pub5-BIB0028|cit28","first-page":"276","article-title":"Biochemical and clinical outcomes following the use of micronised progesterone and dydrogesterone for threatened miscarriage - a randomised controlled trial","volume":"122","author":"Hui","year":"2015","journal-title":"BJOG: an international journal of obstetrics and gynaecology"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1056\/NEJM197510022931401","article-title":"Efficacy of 17alpha-hydroxyprogesterone caproate in the prevention of premature labor","volume":"293","author":"Johnson","year":"1975","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1111\/j.1471-0528.1965.tb01533.x","article-title":"Hormones in recurrent abortion","volume":"72","author":"Klopper","year":"1965","journal-title":"Journal of Obstetrics and Gynaecology of the British Commonwealth"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0031|cit31","first-page":"30","article-title":"Habitual abortion. A controlled clinical study of progestational therapy","volume":"72","author":"Vine","year":"1964","journal-title":"Western Journal of Surgery"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0032|cit32","unstructured":"Luz NP Hormones in the treatment of patients with threatened early pregnancy loss Letter to: Oxford Database of Perinatal Trials, John Radcliffe Infirmary, Oxford"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/j.1471-0528.1965.tb01540.x","article-title":"Double blind controlled trial of 6-methyl-17-acetoxyprogesterone in threatened abortion","volume":"72","author":"Moller","year":"1965","journal-title":"Journal of Obstetrics and Gynaecology of the British Commonwealth"},{"issue":"2","key":"10.1002\/14651858.CD005943.pub5-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/humrep\/17.2.357","article-title":"Progesterone supplementation during early gestations after IVF or ICSI has no effect on the delivery rates: a randomized controlled trial","volume":"17","author":"Nyboe Andersen","year":"2002","journal-title":"Human Reproduction"},{"issue":"5","key":"10.1002\/14651858.CD005943.pub5-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jsbmb.2005.08.013","article-title":"Dydrogesterone in threatened abortion: pregnancy outcome","volume":"97","author":"Omar","year":"2005","journal-title":"Journal of Steroid Biochemistry & Molecular Biology"},{"issue":"18","key":"10.1002\/14651858.CD005943.pub5-BIB0036|cit36","first-page":"3426","article-title":"Alpha lipoic acid (ALA) effects on subchorionic hematoma: preliminary clinical results","volume":"19","author":"Porcaro","year":"2015","journal-title":"European Review for Medical and Pharmacological Sciences"},{"issue":"1","key":"10.1002\/14651858.CD005943.pub5-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/humrep\/7.suppl_1.1","article-title":"The effect of 17alpha-hydroxyprogesterone caproate\/oestradiol valerate on the development and outcome of early pregnancies following in vitro fertilization and embryo transfer: a prospective and randomized controlled trial","volume":"7","author":"Prietl","year":"1992","journal-title":"Human Reproduction"},{"issue":"14","key":"10.1002\/14651858.CD005943.pub5-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1080\/14767058.2017.1330406","article-title":"Effectiveness of dydrogesterone, 17-OH progesterone and micronized progesterone in prevention of preterm birth in women with a short cervix","volume":"31","author":"Pustotina","year":"2018","journal-title":"Journal of Maternal-Fetal & Neonatal Medicine"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1471-0528.1988.tb12797.x","article-title":"Endocrine effects of 17 alpha-hydroxyprogesterone caproate during early pregnancy: a double-blind clinical trial","volume":"95","author":"Reijnders","year":"1988","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1136\/bmj.1.5326.292","article-title":"Double-blind study of effect of 17-hydroxyprogesterone caproate on abortion rate","volume":"1","author":"Shearman","year":"1963","journal-title":"BMJ"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD005943.pub5-BIB0041|cit41","first-page":"243","article-title":"Progesterone for threatened miscarriage: a randomised controlled trial comparing micronised progesterone and dydrogesterone","volume":"27","author":"Siew","year":"2014","journal-title":"Journal of Maternal-Fetal & Neonatal Medicine"},{"issue":"5 Suppl","key":"10.1002\/14651858.CD005943.pub5-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"104S","DOI":"10.1097\/01.AOG.0000463637.28791.c1","article-title":"Micronized progesterone compared with dydrogesterone for threatened miscarriage: a randomized controlled trial","volume":"125","author":"Siew","year":"2015","journal-title":"Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0043|cit43","first-page":"507","article-title":"Randomized prospective trial comparing supplementation of the luteal phase and of early pregnancy by natural progesterone given by intramuscular or vaginal administration","volume":"87","author":"Smitz","year":"1992","journal-title":"Revue Francaise de Gynecologie et d Obstetrique"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0044|cit44","first-page":"1227","article-title":"Progesterone treatment of cases of threatened pre-term delivery in women with a low level of plasma progesterone","volume":"13","author":"Sondergaard","year":"1985","journal-title":"Contraception Fertilite Sexualite"},{"issue":"11","key":"10.1002\/14651858.CD005943.pub5-BIB0045|cit45","first-page":"1025","article-title":"The fetus protection effects of Zhixue Baotai Decoction on women of early threatened abortion with dark area surrounding pregnancy sac","volume":"27","author":"Song","year":"2007","journal-title":"Chinese Journal of Integrated Traditional and Western Medicine"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0090-6980(80)90080-5","article-title":"Therapeutic value of indomethacin in threatened abortion","volume":"19","author":"Souka","year":"1980","journal-title":"Prostaglandins"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1136\/bmj.1.4819.1073","article-title":"Progesterone implantation in habitual abortion","volume":"1","author":"Swyer","year":"1953","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/S0140-6736(80)92496-4","article-title":"Progestagens in threatened abortion","volume":"2","author":"Tognoni","year":"1980","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/0002-9378(66)90173-6","article-title":"Prolonged gynecologic and endocrine manifestations subsequent to administration of medroxyprogesterone acetate during pregnancy","volume":"95","author":"Turner","year":"1966","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD005943.pub5-BIB0050|cit50","first-page":"281","article-title":"Treatment possibilities using progestagens and progesteron-like preparations in threatened abortion","volume":"69","author":"Vincze","year":"2006","journal-title":"Magyar Noorvosok Lapja"},{"issue":"4","key":"10.1002\/14651858.CD005943.pub5-BIB0051|cit51","first-page":"251","article-title":"Clinical and experimental study on yun'an granule in treating threatened abortion","volume":"20","author":"Zhang","year":"2000","journal-title":"Chung-Kuo Chung Hsi i Chieh Ho Tsa Chih"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD005943.pub5-BIB0052|cit52","first-page":"E196","article-title":"To study the impact of progesterone (dydrogesterone) on proinflammatory (IL-6 and TNF-alpha) and anti-inflammatory (IL-10) cytokines in threatened abortion","volume":"131","author":"Yadav","year":"2015","journal-title":"International Journal of Gynecology and Obstetrics"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0053|cit53","unstructured":"ACTRN12611000405910 Does using progesterone in threatened miscarriage increase the live birth rate? Supporting Threatened Outcomes with Progesterone (STOP trial) anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?ACTRN=12611000405910"},{"issue":"Suppl S1","key":"10.1002\/14651858.CD005943.pub5-BIB0054|cit54","first-page":"23","article-title":"Supporting threatened outcomes with progesterone - the stop trial; a protocol","volume":"122","author":"McLindon","year":"2015","journal-title":"BJOG: an international journal of obstetrics and gynaecology"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0055|cit55","unstructured":"IRCT201012035294N1 To investigate the possible effect of Progesterone Supp on cytokines endocervical concentration of women at risk of abortion en.search.irct.ir\/view\/4741"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0056|cit56","unstructured":"IRCT2015020217035N2 Effect of oral progesterone (dydrogestron) on incidence of glucose intolerance in pregnant females with threatened abortion en.search.irct.ir\/view\/22059"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0057|cit57","unstructured":"IRCT2016040627248N1 The efficacy of a special food (fried egg with grape molasses) on threatened abortion: a randomized controlled trial en.search.irct.ir\/view\/29438"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0058|cit58","unstructured":"NCT01501890 The impact of progesterone treatment on obstetrical outcome among women with first trimester vaginal bleeding clinicaltrials.gov\/show\/NCT01501890"},{"issue":"1","key":"10.1002\/14651858.CD005943.pub5-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1186\/s13063-016-1509-8","article-title":"A randomized double-blind controlled trial of the use of dydrogesterone in women with threatened miscarriage in the first trimester: study protocol for a randomized controlled trial","volume":"17","author":"Chan","year":"2016","journal-title":"Trials"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0060|cit60","unstructured":"NCT02128685 A randomized double-blind controlled trial of use of dydrogesterone in women with threatened miscarriage in the first trimester clinicaltrials.gov\/show\/NCT02128685"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0061|cit61","unstructured":"NCT02145767 Progesterone for the prevention of miscarriage and preterm birth in women with first trimester bleeding: PREEMPT trial clinicaltrials.gov\/show\/NCT02145767"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0062|cit62","unstructured":"ChiCTR-IOR-15007526 Chinese herbal medicine and micronized progesterone for threatened miscarriage: an international cooperation multicenter randomized controlled trial chictr.org.cn\/showproj.aspx?proj=12677"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0063|cit63","unstructured":"NCT02633878 Chinese herbal medicine and micronized progesterone for threatened miscarriage RCT clinicaltrials.gov\/ct2\/show\/record\/NCT02633878"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0064|cit64","unstructured":"NCT02690129 Vaginal progesterone for treatment of threatened miscarriage; randomized clinical trial clinicaltrials.gov\/ct2\/show\/NCT02690129"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0065|cit65","unstructured":"NCT02950935 Prospective, double-blind, randomised, placebo controlled, phase iii clinical study assessing the efficacy of natural progesterone 25 mg\/bid administered subcutaneously in the maintenance of early pregnancy in women with symptoms of threatened abortion clinicaltrials.gov\/show\/NCT02950935"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1055\/s-2006-931799","article-title":"Endocrinology of recurrent pregnancy loss","volume":"24","author":"Arredondo","year":"2006","journal-title":"Seminars in Reproductive Medicine"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1471-0528.2007.01426.x","article-title":"A prospective longitudinal population-based study of clinical miscarriage in an urban Swedish population","volume":"115","author":"Blohm","year":"2008","journal-title":"BJOG: an international journal of obstetrics and gynaecology"},{"issue":"12","key":"10.1002\/14651858.CD005943.pub5-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"983","DOI":"10.3109\/09513590.2012.702875","article-title":"A systematic review of dydrogesterone for the treatment of threatened miscarriage","volume":"28","author":"Carp","year":"2012","journal-title":"Gynecological Endocrinology"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0069|cit69","first-page":"5","article-title":"A practical approach to the prevention of miscarriage: part 5--antiphospholipid syndrome as a cause of spontaneous abortion","volume":"38","author":"Check","year":"2011","journal-title":"Clinical and Experimental Obstetrics and Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD005943.pub5-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1186\/s12884-017-1620-1","article-title":"Spontaneous first trimester miscarriage rates per woman among parous women with 1 or more pregnancies of 24 weeks or more","volume":"17","author":"Cohain","year":"2017","journal-title":"BMC Pregnancy and Childbirth"},{"issue":"22","key":"10.1002\/14651858.CD005943.pub5-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1056\/NEJMoa1504927","article-title":"A randomized trial of progesterone in women with recurrent miscarriages","volume":"373","author":"Coomarasamy","year":"2015","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0072|cit72","article-title":"Section IX. Reproductive success and failure","volume-title":"Williams Obstetrics","author":"Cunningham","year":"2001"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0073|cit73","article-title":"Physiology of pregnancy","volume-title":"Williams Obstetrics","author":"Cunningham","year":"2001"},{"issue":"1","key":"10.1002\/14651858.CD005943.pub5-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ijgo.2015.02.023","article-title":"A double-blind randomized controlled trial of mifepristone or placebo before buccal misoprostol for abortion at 14-21 weeks of pregnancy","volume":"130","author":"Dabash","year":"2015","journal-title":"International Journal of Gynecology & Obstetrics"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1093\/humrep\/17.6.1649","article-title":"Paternal age and maternal age are risk factors for miscarriage; results of a multicentre European study","volume":"17","author":"Rochebrochard","year":"2002","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3109\/01443615.2010.489164","article-title":"Fetal loss in threatened abortion after demonstration of fetal cardiac activity in a low socioeconomic population","volume":"30","author":"Dede","year":"2010","journal-title":"Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0077|cit77","unstructured":"Deeks JJ Higgins JPT Altman DG (editors) Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1471-0528.2005.00586.x","article-title":"The changing role of progesterone in preterm labour","volume":"112 Suppl 1","author":"Renzo","year":"2005","journal-title":"BJOG: an international journal of obstetrics and gynaecology"},{"issue":"1","key":"10.1002\/14651858.CD005943.pub5-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/AOG.0000000000002065","article-title":"Progestogens for maintenance tocolysis in women with a short cervix: a randomized controlled trial","volume":"130","author":"Facchinetti","year":"2017","journal-title":"Obstetrics and Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD005943.pub5-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1515\/JPM.2006.062","article-title":"Outcome of fetuses in women with pregestational diabetes mellitus","volume":"34","author":"Galindo","year":"2006","journal-title":"Journal of Perinatal Medicine"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0081|cit81","unstructured":"Editors: Sch\u00fcnemann H Bro\u017cek J Guyatt G Oxman A Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach. Updated October 2013 Available from gdt.guidelinedevelopment.org\/app\/handbook\/handbook.html"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0082|cit82","unstructured":"McMaster University (developed by Evidence Prime) GRADE pro GDT 2015"},{"issue":"[in press]","key":"10.1002\/14651858.CD005943.pub5-BIB0083|cit83","article-title":"Progestogen for preventing miscarriage in women with recurrent miscarriage of unclear etiology","author":"Haas","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD005943.pub5-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/ppe.12142","article-title":"Body size and risk of spontaneous abortion among Danish pregnancy planners","volume":"28","author":"Hahn","year":"2014","journal-title":"Paediatric and Perinatal Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD005943.pub5-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1097\/AOG.0000000000001618","article-title":"17-\u03b1 hydroxyprogesterone caproate for the prevention of recurrent preterm birth: one size may not fit all","volume":"128","author":"Heyborne","year":"2016","journal-title":"Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0087|cit87","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.handbook.cochrane.org"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0088|cit88","unstructured":"Higgins JPT Altman DG Sterne JAC (editors) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0089|cit89","unstructured":"Higgins JPT Deeks JJ Altman DG (editors) Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0090|cit90","first-page":"399","article-title":"The role of progesterone in human early pregnancy is mediated by insulin-like growth factors binding protein1-3","volume":"37","author":"Jin","year":"2006","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1600-0897.2005.00261.x","article-title":"The impact of dydrogesterone supplementation on hormonal profile and progesterone-induced blocking factor concentrations in women with threatened abortion","volume":"53","author":"Kalinka","year":"2005","journal-title":"American Journal of Reproductive Immunology"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/bdra.20645","article-title":"Congenital malformations in infants born after in vitro fertilization in Sweden","volume":"88","author":"K\u00e4ll\u00e9n","year":"2010","journal-title":"Birth Defects Research. Part A Clinical and Molecular Teratology"},{"issue":"3","key":"10.1002\/14651858.CD005943.pub5-BIB0093|cit93","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002857.pub2","article-title":"Uterine muscle relaxant drugs for threatened miscarriage","author":"Lede","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/uog.204","article-title":"Fetal loss following ultrasound diagnosis of a live fetus at 6-10 weeks of gestation","volume":"22","author":"Makrydimas","year":"2003","journal-title":"Ultrasound in Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0095|cit95","first-page":"225","article-title":"Anxiety and depression in pregnant women with previous history of spontaneous abortion","volume":"35 Suppl 1","author":"Marcinko","year":"2011","journal-title":"Collegium Antropologicum"},{"issue":"2","key":"10.1002\/14651858.CD005943.pub5-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/09513590.2015.1121982","article-title":"Dydrogesterone use in early pregnancy","volume":"32","author":"Mirza","year":"2016","journal-title":"Gynecological Endocrinology"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"983","DOI":"10.3109\/14767058.2010.547963","article-title":"Role of the infections in recurrent spontaneous abortion","volume":"24","author":"Nigro","year":"2011","journal-title":"Journal of Maternal Fetal Neonatal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD005943.pub5-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ajog.2015.10.934","article-title":"Prevention of preterm birth with vaginal progesterone or 17-alpha-hydroxyprogesterone caproate: a critical examination of efficacy and safety","volume":"214","author":"O'Brien","year":"2016","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD005943.pub5-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/ijgo.12166","article-title":"Meta-analysis of randomized controlled trials comparing 17\u03b1-hydroxyprogesterone caproate and vaginal progesterone for the prevention of recurrent spontaneous preterm delivery","volume":"138","author":"Oler","year":"2017","journal-title":"International Journal of Gynecology & Obstetrics"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3109\/01443611003605286","article-title":"The diagnostic value of beta-human chorionic gonadotropin, progesterone, CA125 in the prediction of abortions","volume":"30","author":"Osmana\u011fao\u011flu","year":"2010","journal-title":"Journal of Obstetrics and Gynaecology"},{"issue":"1","key":"10.1002\/14651858.CD005943.pub5-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ajog.2003.11.025","article-title":"Can shortened midtrimester cervical length predict very early spontaneous preterm birth?","volume":"191","author":"Owen","year":"2004","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0102|cit102","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00404-010-1439-8","article-title":"Group B streptococci colonization in pregnant women: risk factors and evaluation of the vaginal flora","volume":"283","author":"Rocchetti","year":"2011","journal-title":"Archives of Gynecology and Obstetrics"},{"issue":"4","key":"10.1002\/14651858.CD005943.pub5-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.ajog.2005.01.076","article-title":"Does the presence of a funnel increase the risk of adverse perinatal outcome in a patient with a short cervix?","volume":"192","author":"Rust","year":"2005","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD005943.pub5-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.fertnstert.2016.10.031","article-title":"Supplementation with progestogens in the first trimester of pregnancy to prevent miscarriage in women with unexplained recurrent miscarriage: a systematic review and meta-analysis of randomized, controlled trials","volume":"107","author":"Saccone","year":"2017","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1471-0528.2009.02427.x","article-title":"Maternal and perinatal outcome in women with threatened miscarriage in the first trimester: a systematic review","volume":"117","author":"Saraswat","year":"2010","journal-title":"BJOG: an international journal of obstetrics and gynaecology"},{"issue":"6","key":"10.1002\/14651858.CD005943.pub5-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/S0022-5347(05)68863-5","article-title":"In vitro fertilization is associated with an increased risk of hypospadias","volume":"161","author":"Silver","year":"1999","journal-title":"Journal of Urology"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0108|cit108","unstructured":"Sterne JAC Egger M Moher D (editors) Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Intervention. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1600-0897.2009.00741.x","article-title":"Live birth rate according to maternal age and previous number of recurrent miscarriages","volume":"62","author":"Sugiura-Ogasawara","year":"2009","journal-title":"American Journal of Reproductive Immunology"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.2174\/092986710793176302","article-title":"Genetic factors as a cause of miscarriage","volume":"17","author":"Suzumori","year":"2010","journal-title":"Current Medicinal Chemistry"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.2741\/2817","article-title":"Role of progesterone and progestin therapy in threatened abortion and preterm labour","volume":"13","author":"Szekeres-Bartho","year":"2008","journal-title":"Frontiers in Bioscience"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"873","DOI":"10.2217\/imt.09.54","article-title":"Progesterone-mediated immunomodulation in pregnancy: its relevance to leukocyte immunotherapy of recurrent miscarriage","volume":"1","author":"Szekeres-Bartho","year":"2009","journal-title":"Immunotherapy"},{"issue":"2","key":"10.1002\/14651858.CD005943.pub5-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1600-0897.2010.00833.x","article-title":"PIBF: the double edged sword. Pregnancy and tumor","volume":"64","author":"Szekeres-Bartho","year":"2010","journal-title":"American Journal of Reproductive Immunology"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0114|cit114","first-page":"418","article-title":"The role of maternal syphilis, gonorrhoea and HIV-1 infection in spontaneous abortion","volume":"3","author":"Temmerman","year":"1992","journal-title":"International Journal of Sexually Transmitted Diseases and AIDS"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1369\/jhc.4A6424.2005","article-title":"Evidence for high frequency of chromosomal mosaicism in spontaneous abortions revealed by interphase FISH analysis","volume":"53","author":"Vorsanova","year":"2005","journal-title":"Journal of Histochemistry and Cytochemistry"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0116|cit116","unstructured":"World Bank World Bank list of economies iccmoot.com\/wp-content\/uploads\/2017\/07\/World-Bank-List-of-Economies.pdf"},{"key":"10.1002\/14651858.CD005943.pub5-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1016\/j.fertnstert.2009.09.009","article-title":"International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) revised glossary of ART terminology","volume":"92","author":"Zegers-Hochschild","year":"2009","journal-title":"Fertility and Sterility"},{"issue":"12","key":"10.1002\/14651858.CD005943.pub5-BIB0118|cit118","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005943.pub4","article-title":"Progestogen for treating threatened miscarriage","author":"Wahabi","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD005943.pub5\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T20:26:23Z","timestamp":1720470383000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD005943.pub5"}},"subtitle":[],"editor":[{"name":"Cochrane Pregnancy and Childbirth Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,8,6]]},"references-count":118,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,9]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd005943.pub5","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,6]]}}}